Find similar content

Source channel @githubtrending · Post #14784 · Jun 4

#vue#awesome#dashboard#docker#hacktoberfest#homelab#homepage#mit#nodejs#organization#productivity#pwa#self_hosted#startpage#vue Dashy is a free, open-source dashboard that lets you organize and access all your self-hosted services, apps, and web links from one central place, making it easy to manage and monitor everything you use regularly[1][2][4]. It comes with over 50 pre-built widgets for things like system monitoring, news, weather, and productivity, and you can customize the look and layout with themes, icons, and different views[4][5]. The main benefit is that Dashy saves you time and hassle by giving you a single, user-friendly page to launch and check on all your important services, with features like instant search, status indicators, and multi-language support[4][5]. https://github.com/Lissy93/dashy

Hashtags

#vue #awesome #dashboard #docker #hacktoberfest #homelab #homepage #mit #nodejs #organization #productivity #pwa #self_hosted #startpage

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment